Maternal characteristics and mid-pregnancy serum biomarkers as risk factors for subtypes of preterm birth

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 122, Issue 11, 2015, Pages 1484-1493

  Jelliffe Pawlowski, L L ^a,b   Baer, R J ^a   Blumenfeld, Y J ^c   Ryckman, K K ^d   O'Brodovich, H M ^c   Gould, J B ^c,e   Druzin, M L ^c   El Sayed, Y Y ^b   Lyell, D J ^c   Stevenson, D K ^c   Shaw, G M ^c   Currier, R J ^a  

^a CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e California Perinatal Quality Care Collaborative   (United States)

Author keywords

Medically indicated preterm birth; risk factors; serum biomarkers; spontaneous preterm birth

Indexed keywords

ALPHA FETOPROTEIN; BIOLOGICAL MARKER; INHIBIN A; PROTEIN A; INHIBIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADOLESCENT; ADULT; ANEMIA; ARTICLE; BLACK PERSON; CESAREAN SECTION; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; ETHNICITY; FEMALE; FIRST TRIMESTER PREGNANCY; HIGH RISK PREGNANCY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; POPULATION RESEARCH; PREECLAMPSIA; PREMATURE LABOR; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; RISK REDUCTION; SECOND TRIMESTER PREGNANCY; UNITED STATES; ANCESTRY GROUP; BLOOD; CALIFORNIA; CLASSIFICATION; FAMILY PLANNING; PREGNANCY; PREGNANCY COMPLICATIONS; PREMATURE BIRTH; RISK FACTOR; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; ALPHA-FETOPROTEINS; ANEMIA; BIOMARKERS; BIRTH INTERVALS; CALIFORNIA; CESAREAN SECTION; COHORT STUDIES; CONTINENTAL POPULATION GROUPS; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; INHIBINS; LOGISTIC MODELS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PREMATURE BIRTH; RISK FACTORS; YOUNG ADULT;

EID: 84942553546     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.13495     Document Type: Article

References (66)

1. Vohr BR, Wright LL, Poole WK, McDonald SA,. Neurodevelopmental outcomes of extremely low birth weight infants <32 weeks' gestation between 1993 and 1998. Pediatrics 2005; 116: 635-43.
2. Tomashek KM, Shapiro-Mendoza CK, Davidoff MJ, Petrini JR,. Differences in mortality between late-preterm and term singleton infants in the United States, 1995-2002. J Pediatr 2007; 151: 450-6, 456.
3. Swamy GK, Ostbye T, Skjaerven R,. Association of preterm birth with long-term survival, reproduction, and next-generation preterm birth. JAMA 2008; 299: 1429-36.
4. Melamed N, Klinger G, Tenenbaum-Gavish K, Herscovici T, Linder N, Hod M, et al., Short-term neonatal outcome in low-risk, spontaneous, singleton, late preterm deliveries. Obstet Gynecol 2009; 114: 253-60.
5. Doyle LW, Roberts G, Anderson PJ,. Outcomes at age 2 years of infants < 28 weeks' gestational age born in Victoria in 2005. J Pediatr 2010; 156: 49-53.
6. Stoll BJ, Hansen NI, Bell EF, Shankaran S, Laptook AR, Walsh MC, et al., Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010; 126: 443-56.
7. Crump C, Sundquist K, Sundquist J, Winkleby MA,. Gestational age at birth and mortality in young adulthood. JAMA 2011; 306: 1233-40.
8. Leone A, Ersfeld P, Adams M, Schiffer PM, Bucher HU, Arlettaz R,. Neonatal morbidity in singleton late preterm infants compared with full-term infants. Acta Paediatr 2012; 101: e6-10.
9. Parkinson JR, Hyde MJ, Gale C, Santhakumaran S, Modi N,. Preterm birth and the metabolic syndrome in adult life: a systematic review and meta-analysis. Pediatrics 2013; 131: e1240-63.
10. Morken NH, Kallen K, Jacobsson B,. Outcomes of preterm children according to type of delivery onset: a nationwide population-based study. Paediatr Perinat Epidemiol 2007; 21: 458-64.
11. Bastek JA, Srinivas SK, Sammel MD, Elovitz MA,. Do neonatal outcomes differ depending on the cause of preterm birth? A comparison between spontaneous birth and iatrogenic delivery for preeclampsia. Am J Perinatol 2010; 27: 163-9.
12. Lisonkova S, Hutcheon JA, Joseph KS,. Temporal trends in neonatal outcomes following iatrogenic preterm delivery. BMC Pregnancy Childbirth 2011; 11: 39.
13. Schaaf JM, Mol BW, Abu-Hanna A, Ravelli AC,. Ethnic disparities in the risk of adverse neonatal outcome after spontaneous preterm birth. Acta Obstet Gynecol Scand 2012; 91: 1402-8.
14. Spong CY,. Prediction and prevention of recurrent spontaneous preterm birth. Obstet Gynecol 2007; 110: 405-15.
15. McManemy J, Cooke E, Amon E, Leet T,. Recurrence risk for preterm delivery. Am J Obstet Gynecol 2007; 196: 576.
16. Mella MT, Berghella V,. Prediction of preterm birth: cervical sonography. Semin Perinatol 2009; 33: 317-24.
17. Hassan SS, Romero R, Vidyadhari D, Fusey S, Baxter JK, Khandelwal M, et al., Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2011; 38: 18-31.
18. The American College of Obstetricians and Gynecologists. Practice bulletin no. 130: prediction and prevention of preterm birth. Obstet Gynecol 2012; 120: 964-73.
19. Berghella V,. Cerclage decreases preterm birth: finally the level I evidence is here. Am J Obstet Gynecol 2011; 205: 89-90.
20. Sibai BM, Caritis SN, Hauth JC, MacPherson C, VanDorsten JP, Klebanoff M, et al., Preterm delivery in women with pregestational diabetes mellitus or chronic hypertension relative to women with uncomplicated pregnancies. The National institute of Child health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 2000; 183: 1520-4.
21. Catov JM, Nohr EA, Olsen J, Ness RB,. Chronic hypertension related to risk for preterm and term small for gestational age births. Obstet Gynecol 2008; 112: 290-6.
22. Goldenberg RL, Culhane JF, Iams JD, Romero R,. Epidemiology and causes of preterm birth. Lancet 2008; 371: 75-84.
23. Dugoff L,. First- and second-trimester maternal serum markers for aneuploidy and adverse obstetric outcomes. Obstet Gynecol 2010; 115: 1052-61.
24. Romero J, Rebarber A, Saltzman DH, Schwartz R, Peress D, Fox NS,. The prediction of recurrent preterm birth in patients on 17-α-hydroxyprogesterone caproate using serial fetal fibronectin and cervical length. Am J Obstet Gynecol 2012; 207: 51-5.
25. Jelliffe-Pawlowski LL, Shaw GM, Currier RJ, Stevenson DK, Baer RJ, O'Brodovich HM, et al., Association of early-preterm birth with abnormal levels of routinely collected first- and second-trimester biomarkers. Am J Obstet Gynecol 2013; 208: 492.e1-11.
26. Cnattingius S, Villamor E, Johansson S, Edstedt Bonamy AK, Persson M, Wikstrom AK, et al., Maternal obesity and risk of preterm delivery. JAMA 2013; 309: 2362-70.
27. Lynch AM, Hart JE, Agwu OC, Fisher BM, West NA, Gibbs RS,. Association of extremes of prepregnancy BMI with the clinical presentations of preterm birth. Am J Obstet Gynecol 2014; 210: 428.e1-9.
28. Hammond G, Langridge A, Leonard H, Hagan R, Jacoby P, DeKlerk N, et al., Changes in risk factors for preterm birth in Western Australia 1984-2006. BJOG 2013; 120: 1051-60.
29. Joseph KS, Fahey J, Shankardass K, Allen VM, O'Campo P, Dodds L, et al., Effects of socioeconomic position and clinical risk factors on spontaneous and iatrogenic preterm birth. BMC Pregnancy Childbirth 2014; 14: 117.
30. Morisaki N, Togoobaatar G, Vogel JP, Souza JP, Rowland Hogue CJ, Jayaratne K, et al., Risk factors for spontaneous and provider-initiated preterm delivery in high and low Human Development Index countries: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG 2014; 121 (Suppl 1): 101-9.
31. Currier R, Wu N, Van MK, Goldman S, Lorey F, Flessel M,. Integrated and first trimester prenatal screening in California: program implementation and patient choice for follow-up services. Prenat Diagn 2012; 32: 1077-83.
32. Crombag NM, Vellinga YE, Kluijfhout SA, Bryant LD, Ward PA, Iedema-Kuiper R, et al., Explaining variation in Down's syndrome screening uptake: comparing the Netherlands with England and Denmark using documentary analysis and expert stakeholder interviews. BMC Health Serv Res 2014; 14: 437.
33. Kaur G, Srivastav J, Kaur A, Huria A, Goel P, Kaur R, et al., Maternal serum second trimester screening for chromosomal disorders and neural tube defects in a government hospital of North India. Prenat Diagn 2012; 32: 1192-6.
34. Handschuh K, Guibourdenche J, Guesnon M, Laurendeau I, Evain-Brion D, Fournier T,. Modulation of PAPP-A expression by PPARgamma in human first trimester trophoblast. Placenta 2006; 27 (Suppl A): S127-34.
35. Mizejewski GJ,. Physiology of α-fetoprotein as a biomarker for perinatal distress: relevance to adverse pregnancy outcome. Exp Biol Med (Maywood) 2007; 232: 993-1004.
36. Norwitz ER,. Defective implantation and placentation: laying the blueprint for pregnancy complications. Reprod Biomed Online 2007;14 Spec No 1: 101-9.
37. Fitzgerald B, Levytska K, Kingdom J, Walker M, Baczyk D, Keating S,. Villous trophoblast abnormalities in extremely preterm deliveries with elevated second trimester maternal serum hCG or inhibin-A. Placenta 2011; 32: 339-45.
38. Dugoff L, Hobbins JC, Malone FD, Porter TF, Luthy D, Comstock CH, et al., First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol 2004; 191: 1446-51.
39. Dugoff L, Hobbins JC, Malone FD, Vidaver J, Sullivan L, Canick JA, et al., Quad screen as a predictor of adverse pregnancy outcome. Obstet Gynecol 2005; 106: 260-7.
40. Spencer K, Cowans NJ, Molina F, Kagan KO, Nicolaides KH,. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery. Ultrasound Obstet Gynecol 2008; 31: 147-52.
41. Jelliffe-Pawlowski LL, Baer RJ, Currier RJ,. Second trimester serum predictors of preterm birth in a population-based sample of low-risk pregnancies. Prenat Diagn 2010; 30: 727-33.
42. Lydon-Rochelle MT, Holt VL, Cardenas V, Nelson JC, Easterling TR, Gardella C, et al., The reporting of pre-existing maternal medical conditions and complications of pregnancy on birth certificates and in hospital discharge data. Am J Obstet Gynecol 2005; 193: 125-34.
43. Korst LM, Fridman M, Lu MC, Mitchell C, Lawton E, Griffin F, et al., Monitoring childbirth morbidity using hospital discharge data: further development and application of a composite measure. Am J Obstet Gynecol 2014; 211: 268.
44. Huang T, Hoffman B, Meschino W, Kingdom J, Okun N,. Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome. Prenat Diagn 2010; 30: 471-7.
45. Alleman BW, Smith AR, Byers HM, Bedell B, Ryckman KK, Murray JC, et al., A proposed method to predict preterm birth using clinical data, standard maternal serum screening, and cholesterol. Am J Obstet Gynecol 2013; 208: 472-511.
46. Dane B, Dane C, Batmaz G, Ates S, Dansuk R,. First trimester maternal serum pregnancy-associated plasma protein-A is a predictive factor for early preterm delivery in normotensive pregnancies. Gynecol Endocrinol 2013; 29: 592-5.
47. D'Antonio F, Rijo C, Thilaganathan B, Akolekar R, Khalil A, Papageourgiou A, et al., Association between first-trimester maternal serum pregnancy-associated plasma protein-A and obstetric complications. Prenat Diagn 2013; 33: 839-47.
48. Barros FC, Papageorghiou AT, Victora CG, Noble JA, Pang R, Iams J, et al., The distribution of clinical phenotypes of preterm birth syndrome: implications for prevention. JAMA Pediatr 2015; 169: 220-9.
49. Sibai BM, Koch MA, Freire S, Pinto e Silva JL, Rudge MV, Martins-Costa S, et al., The impact of prior preeclampsia on the risk of superimposed preeclampsia and other adverse pregnancy outcomes in patients with chronic hypertension. Am J Obstet Gynecol 2011; 204: 345-6.
50. Bramham K, Parnell B, Nelson-Piercy C, Seed PT, Poston L, Chappell LC,. Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis. BMJ 2014; 348: g2301.
51. Kim YM, Chaiworapongsa T, Gomez R, Bujold E, Yoon BH, Rotmensch S, et al., Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol 2002; 187: 1137-42.
52. Palei AC, Spradley FT, Warrington JP, George EM, Granger JP,. Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology. Acta Physiol (Oxf) 2013; 208: 224-33.
53. Poon LC, Volpe N, Muto B, Yu CK, Syngelaki A, Nicolaides KH,. Second-trimester uterine artery Doppler in the prediction of stillbirths. Fetal Diagn Ther 2013; 33: 28-35.
54. Zhu BP, Rolfs RT, Nangle BE, Horan JM,. Effect of the interval between pregnancies on perinatal outcomes. N Engl J Med 1999; 340: 589-94.
55. Reagan PB, Salsberry PJ,. Race and ethnic differences in determinants of preterm birth in the USA: broadening the social context. Soc Sci Med 2005; 60: 2217-28.
56. Conde-Agudelo A, Rosas-Bermudez A, Kafury-Goeta AC,. Birth spacing and risk of adverse perinatal outcomes: a meta-analysis. JAMA 2006; 295: 1809-23.
57. Kramer MR, Hogue CR,. Place matters: variation in the black/white very preterm birth rate across U.S. metropolitan areas, 2002-2004. Public Health Rep 2008; 123: 576-85.
58. Shen TT, DeFranco EA, Stamilio DM, Chang JJ, Muglia LJ,. A population-based study of race-specific risk for preterm premature rupture of membranes. Am J Obstet Gynecol 2008; 199: 373-7.
59. Carter MF, Fowler S, Holden A, Xenakis E, Dudley D,. The late preterm birth rate and its association with comorbidities in a population-based study. Am J Perinatol 2011; 28: 703-7.
60. Lisonkova S, Joseph KS,. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol 2013; 209: 544.
61. Cohen JL, Smilen KE, Bianco AT, Moshier EL, Ferrara LA, Stone L,. Predictive value of combined serum biomarkers for adverse pregnancy outcomes. Eur J Obstet Gynecol Reprod Biol 2014; 181C: 89-94.
62. Odibo AO, Patel KR, Spitalnik A, Odibo L, Huettner P,. Placental pathology, first-trimester biomarkers and adverse pregnancy outcomes. J Perinatol 2014; 34: 186-91.
63. Stein CR, Savitz DA, Janevic T, Ananth CV, Kaufman JS, Herring AH, et al., Maternal ethnic ancestry and adverse perinatal outcomes in New York City. Am J Obstet Gynecol 2009; 201: 584-9.
64. Shaw GM, Wise PH, Mayo J, Carmichael SL, Ley C, Lyell DJ, et al., Maternal Prepregnancy Body Mass Index and Risk of Spontaneous Preterm Birth. Paediatr Perinat Epidemiol 2014; 28: 302-11.
65. Betran AP, Merialdi M, Lauer JA, Bing-Shun W, Thomas J, Van LP, et al., Rates of caesarean section: analysis of global, regional and national estimates. Paediatr Perinat Epidemiol 2007; 21: 98-113.
66. Gibbons L, Belizan JM, Lauer JA, Betran AP, Merialdi M, Althabe F,. Inequities in the use of cesarean section deliveries in the world. Am J Obstet Gynecol 2012; 206: 331-19.